Global Respiratory Drug Market Research Report 2022

Respiratory drug is a term used to describe a wide variety of medicines used to relieve, treat, or prevent respiratory diseases such as asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), or pneumonia.
Due to the COVID-19 pandemic, the global Respiratory Drug market size is estimated to be worth US$ 43040 million in 2021 and is forecast to a readjusted size of US$ 64160 million by 2028 with a CAGR of 5.8% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Respiratory Drug market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Respiratory Drug landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The classification of Respiratory Drug includes Inhalable & Nasal Spray, Oral and Others, and the proportion of Inhalable & Nasal Spray in 2019 is about 68.82%.
Respiratory Drug widely sold through Hospital and Drugs Store. The most proportion of Respiratory Drug sold through Drugs Store, and the proportion in 2019 is 58.28%.
North America is the largest consumption place, with a consumption market share nearly 35.24% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 28.58%. Moreover, the Asian market is expected to register the highest CAGR during the forecast period.
Market competition is intense. GSK, AstraZeneca, Boehringer Ingelheim, Vertex, Roche, etc. are the leaders of the industry.
This report focuses on Respiratory Drug volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Respiratory Drug market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, India and China, etc.
Global Respiratory Drug Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Inhalable & Nasal Spray
Oral
Others
Segment by Application
Hospital
Drugs Store
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
GSK
AstraZeneca
Boehringer Ingelheim
Vertex
Roche
Novartis
Teva
Chiesi
Mylan
Sumitomo Dainippon
Merck
Beximco